Article Information
Published By
History
- Received March 14, 2020
- Accepted June 8, 2020
- Published online August 15, 2020.
Copyright & Usage
Copyright: © 2020, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Author Information
- 1Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
- Correspondence to: Xiubao Ren, E-mail: renxiubao{at}tjmuch.com
Cited By...
In this issue
Jump to section
- Article
- Abstract
- Introduction
- Immune cells with high expression of PD-1 or PD-L1 help predict tumor progression and prognosis
- Effects of immune cells with high expression of PD-1 or PD-L1 in tumor immunity
- Regulation of PD-1 or PD-L1 expression on immune cells in tumor immunity
- Potential therapeutic strategies of anti-PD-L1/PD-1 therapy
- Conclusions
- Acknowledgments
- Footnotes
- References
- Figures & Data
- Info & Metrics
- References